C-TRI Overview
- Founded
-
1998
- Status
-
Acquired/Merged
- Employees
-
153
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
2
C-TRI General Information
Description
Mediforum Pharmaceutical Inc Inc is a research-oriented pharmaceutical company. It is engaged in developing Peptide drugs, Antiviral drugs and Ionic liquids. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and others.
Contact Information
Website
www.medipharms.co.kr
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Mediforum
Former Stock Listing
047920
Primary Office
- 778-1 Ilpaedong
- Gyeonggangro, Gyeonggi-do
- Namyangiu, 472-930
- South Korea
+82 000-000-0000
C-TRI Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
C-TRI Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Wan-joo Kim | Founder, President & Chief Executive Officer |
C-TRI Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
C-TRI Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
C-TRI Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000 | 27-Apr-2021 | 0000 00000 | 0000 | Drug Discovery | |
| SuperTrans Medical | 07-Apr-2020 | Corporate | 000 | Pharmaceuticals |